Lv1
60 积分 2025-08-15 加入
Antibody–drug conjugates come of age in oncology
1个月前
已完结
Determination of protease cleavage site motifs using mixture-based oriented peptide libraries
1个月前
已完结
Antibody–Prodrug Conjugates with KSP Inhibitors and Legumain‐Mediated Metabolite Formation
1个月前
已完结
Enhancing the bystander effect of antibody-drug conjugate by using a novel caspase-3 cleavable peptide linker to overcome tumor heterogeneity
1个月前
已完结
Bystander killing effect of DS‐8201a, a novel anti‐human epidermal growth factor receptor 2 antibody–drug conjugate, in tumors with human epidermal growth factor receptor 2 heterogeneity
2个月前
已完结
The structural basis of camptothecin interactions with human serum albumin: impact on drug stability
2个月前
已完结
Current State of the Art in HPLC Methodology for Lipophilicity Assessment of Basic Drugs. A Review
2个月前
已完结
Recent Advances in Peptide Linkers for Antibody-Drug Conjugates
2个月前
已完结
Antibody–Drug Conjugates with Pyrrole‐Based KSP Inhibitors as the Payload Class
2个月前
已完结
Antibody–Prodrug Conjugates with KSP Inhibitors and Legumain‐Mediated Metabolite Formation
3个月前
已完结
皖公网安备34019202002308
